Clinical Trial Update: Dose-relationship of Vaginally Administrated Oxytocin in Postmenopausal Women [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating dose relationship of vaginally administered oxytocin in postmenopausal women with vaginal atrophy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vaginal Atrophy

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: PepTonic Medical AB | Conditions: Vaginal Atrophy | Phase 2 | Status: COMPLETED